Trial Profile
The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Gestational Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Gestational diabetes; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GDM-TREAT
- 03 Nov 2020 Status changed from active, no longer recruiting to completed.
- 06 Oct 2019 According to European Clinical Trials Database record, trial is completed at Denmark (Global End Date: 2-Sep-2019).
- 15 Sep 2017 Results (n=102) presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.